Consultant to Cambridge gene therapy firm charged with insider trading

A biotech consultant who advised Cambridge gene therapy firm Dimension Therapeutics on a potential acquisition in 2017 has been charged with insider trading. Mark Joseph Ahn, a 58-year-old biotech consultant based in Lake Oswego, Oregon, is facing parallel criminal charges from the U.S. Attorney's Office for the District of Massachusetts and civil charges from the U.S. Securities and Exchange Commission. The charging bodies allege that while working as a consultant for New York-based Abeona Therapeutics,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news